You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Litigation Details for BAUSCH HEALTH IRELAND LIMITED v. MYLAN LABORATORIES LTD. (N.D.W. Va. 2022)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in BAUSCH HEALTH IRELAND LIMITED v. MYLAN LABORATORIES LTD.
The small molecule drug covered by the patents cited in this case is ⤷  Sign Up .

Details for BAUSCH HEALTH IRELAND LIMITED v. MYLAN LABORATORIES LTD. (N.D.W. Va. 2022)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2023-01-12 149 Memorandum the ’097 patent unless otherwise noted. 2 U.S. Patent Nos. 10,011,637 (“’637 patent”); 11,142,5499,616,097 (“’097 patent”); 9,610,321 (“’321 patent”); 9,919,024 (“’024 patent”), and 9,925,231 (“’231 patent…BACKGROUND Two patent families are at issue for claim construction. One patent family shares a common…the “purified plecanatide patents”).2 With respect to both patent families, non-party Synergy…originally filed the patent applications (in the 2010-2013 timeframe) and prosecuted the patents. Synergy also External link to document
2023-03-30 199 Order on Motion to Strike AND Memorandum & Opinion AND Order on Motion to Dismiss for Failure AND Order on Motion for Judgment on the Pleadings 231 patent”), 10,011,637 (“the ’637 patent”), 11,142,549 (“the ’549 patent”), and 11,319,346 (“the ’346…2 includes the ’321 patent, the ’097 patent, the ’024 patent, and the ’231 patent, which disclose and…Mylan 1 The patents-in-suit are United States Patent Nos. 7,041,786 (“the ’786 patent”), 9,610,321 (… (“the ’321 patent”), 9,616,097 (“the ’097 patent”), 9,919,024 (“the ’024 patent”), 9,925,231 (“the ’231…Id. These patents fall into three patent families. Family 1 includes the ’786 patent, which discloses External link to document
2022-03-08 55 Memorandum & Opinion 024 patent”), 9,925,231 (“the ‘231 patent”) and 10,011,637 (“the ‘637 patent”).) As part of… United States Patents Nos. 7,041,786 (“the ‘786 patent”), 7,799,897 (“the ‘897 patent”), 8,637,451 (… (“the ‘451 patent”), 9,610,321 (“the ‘321 patent”), 9,616,097 (“the ‘097 patent”), 9,919,024 (“the ‘…approval to market a drug while that drug is on-patent is patent infringement. 35 U.S.C. § 271(e)(2); see …infringing upon the original drug’s patent by waiting out the patent’s term. If so, the applicant includes External link to document
2022-05-05 91 Amended Complaint the ’097 patent”), 9,919,024 (“the ’024 patent”), 9,925,231 (“the ’231 patent”) and 10,011,637 (“the ’…786 patent, the ’321 patent, the ’097 patent, the ’024 patent, the ’231 patent or the ’637 patent. …786 patent, the ’321 patent, the ’097 patent, the ’024 patent, the ’231 patent and the ’637 patent; … of the ’786 patent, the ’321 patent, the ’097 patent, the ’024 patent, the ’231 patent and the ’637 … of the ’786 patent, the ’321 patent, the ’097 patent, the ’024 patent, the ’231 patent and the ’637 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.